Although the results showed a trend towards a lower relapse rate for patients who received the higher dose of cytarabine, OS was not significantly different.
← all excerpts
Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy.
1
—
—